We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Drug Targets – Products

FDA compliant tissue microarray.
Product News

Regulatory Compliant Tissue Microarrays

AMSBIO reports that its extensive range of FDA tissue microarrays reliably enhances tissue cross-reactivity (TCR) and other target validation studies.
A strand of RNA.
Product News

CatSci Ltd Win Welsh Government SMART Capital Equipment Grant for Innovative Oligonucleotides Development

CatSci Ltd are thrilled to announce that they have won a Welsh Government SMART Capital Equipment Fund grant to enhance their oligonucleotides capability and offer more and better R&D and manufacturing solutions to customers.
Pills on a target.
Product News

Cresset® Announces Global Collaboration With Enamine on New Virtual Screening Drug Discovery Technology

Cresset, announces a collaboration with Enamine to develop innovative new solutions for the early drug discovery process.
1.2 GHz NMR Installation.
Product News

Bruker Announces First 1.2 GHz NMR Installation in the United States

Novel GHz-class NMR systems are enabling unprecedented life science and materials research in functional structural biology, drug discovery, metabolomics and cleantech

Developments in Drug Discovery & Targeting

Download this compendium to learn more about developments in high-throughput screening, target-based drug discovery and fragment-based drug discovery.
Engaging in research is like participating in a high-stakes poker match.

Don't Gamble With Your Research: The Winning Hand of Label-Free Protein Characterization

Engaging in research is like participating in a high-stakes poker match. The potential reward? The discovery of the next blockbuster drug. The gamble? Risking billions on a molecule that doesn't pay off. In this game, the winning hand lies in the tools that can identify the most promising leads.
Determine Kinetics Earlier in the Drug Discovery Process
App Note / Case Study

Determine Kinetics Earlier in the Drug Discovery Process

This app note highlights how reliable kinetics and affinity for high-affinity interactions can be obtained from significantly less data than is commonly used.
Bio-Rad Anti-dupilumab Antibodies.
Product News

Bio-Rad Extends Range of Anti-Idiotypic Antibodies for Use in Preclinical and Clinical Drug Development

Range of highly selective anti-idiotypic antibodies now includes six antibodies specific to dupilumab and its biosimilars for bioanalysis and Drug Monitoring.
Drug Kinetics SPR

Optimize Your Affinity and Kinetics Data Analysis

Accurate kinetics and affinity data is essential for predicting the efficacy of novel therapeutics and for making quick decisions about weak candidates. However, analysis methods that require labelling can cause steric interference and influence data outcomes.
Sygnature Discovery logo.
Product News

Sygnature Discovery Launches Its LPS In Vivo Model To Profile Early-Stage Anti-Inflammatory Drugs

Sygnature Discovery has established an in vivo LPS model of inflammation which can help understand life-limiting neuroinflammatory conditions like Parkinson’s disease, multiple sclerosis, Alzheimer’s disease, and traumatic brain injuries and identify new drug targets.